Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 8/24/10 AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100 8/23/10 Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses 8/9/10 AVI BioPharma Announces Second Quarter 2010 Financial Results 8/2/10 AVI BioPharma Announces Second Quarter 2010 Financial Results and Corporate Update Conference Call 7/29/10 AVI BioPharma to Present at BMO Capital Markets Focus on Healthcare Conference 7/20/10 AVI BioPharma Awarded up to $291 Million U.S. Government Contract for Advanced Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses 7/16/10 AVI BioPharma Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at International Congress on Neuromuscular Diseases 7/16/10 AVI BioPharma Discloses New Contract With U.S. Government for Potential Funding of up to $291 Million to Advance Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses 7/7/10 AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy 6/10/10 AVI BioPharma to Present at ThinkEquity's Mid Year Check-Up on Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 59 Page 60 Page 61 Page 62 Current page 63 Page 64 Page 65 Page 66 Page 67 … Next page next › Last page last » Displaying 621 - 630 of 816 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 8/24/10 AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100 8/23/10 Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses 8/9/10 AVI BioPharma Announces Second Quarter 2010 Financial Results 8/2/10 AVI BioPharma Announces Second Quarter 2010 Financial Results and Corporate Update Conference Call 7/29/10 AVI BioPharma to Present at BMO Capital Markets Focus on Healthcare Conference 7/20/10 AVI BioPharma Awarded up to $291 Million U.S. Government Contract for Advanced Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses 7/16/10 AVI BioPharma Announces Presentations on Exon Skipping Drug AVI-4658 for Treatment of Duchenne Muscular Dystrophy at International Congress on Neuromuscular Diseases 7/16/10 AVI BioPharma Discloses New Contract With U.S. Government for Potential Funding of up to $291 Million to Advance Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses 7/7/10 AVI BioPharma Opens Investigational New Drug (IND) Application for AVI-4658 in Duchenne Muscular Dystrophy 6/10/10 AVI BioPharma to Present at ThinkEquity's Mid Year Check-Up on Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 59 Page 60 Page 61 Page 62 Current page 63 Page 64 Page 65 Page 66 Page 67 … Next page next › Last page last » Displaying 621 - 630 of 816